Spots Global Cancer Trial Database for nodal marginal zone lymphoma
Every month we try and update this database with for nodal marginal zone lymphoma cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
| Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
|---|---|---|---|---|---|---|
| Bortezomib and Flavopiridol in Treating Patients With Recurrent or Refractory Indolent B-Cell Neoplasms | NCT00082784 | Extranodal Marg... Nodal Marginal ... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Grade... Recurrent Grade... Recurrent Grade... Recurrent Mantl... Recurrent Margi... Refractory Plas... Splenic Margina... Waldenstrom Mac... | Bortezomib Alvocidib Hydro... Pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Yttrium Y 90 Ibritumomab Tiuxetan and Rituximab in Treating Patients With Previously Untreated Marginal Zone Lymphoma | NCT00453102 | Marginal Zone L... | Rituximab Ibritumomab Tiu... | 18 Years - 120 Years | University of Miami | |
| Copanlisib in Combination With Venetoclax in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma. | NCT03886649 | Non-Hodgkin Lym... | Copanlisib Venetoclax | 18 Years - | Swiss Group for Clinical Cancer Research | |
| Tumor Registry of Lymphatic Neoplasia | NCT00889798 | Non-Hodgkin's L... Chronic Lymphoc... Multiple Myelom... | 18 Years - | iOMEDICO AG | ||
| Vorinostat in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma | NCT00253630 | Extranodal Marg... Nodal Marginal ... Recurrent Grade... Recurrent Grade... Recurrent Grade... Recurrent Mantl... Recurrent Margi... | Laboratory Biom... Vorinostat | 18 Years - | National Cancer Institute (NCI) | |
| Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma | NCT05700149 | Nodal Marginal ... | 18 Years - | International Extranodal Lymphoma Study Group (IELSG) | ||
| Rituximab, Cyclophosphamide, Bortezomib, and Dexamethasone in Treating Patients With Relapsed or Refractory Low-Grade Follicular Lymphoma, Waldenstrom Macroglobulinemia, or Mantle Cell Lymphoma | NCT00711828 | Extranodal Marg... Nodal Marginal ... Recurrent Grade... Recurrent Grade... Recurrent Mantl... Recurrent Small... Refractory Chro... Splenic Margina... Waldenstrom Mac... | Bortezomib Rituximab Cyclophosphamid... Dexamethasone Questionnaire A... Quality-of-Life... | 18 Years - | Mayo Clinic | |
| Copanlisib in Combination With Venetoclax in Patients With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma. | NCT03886649 | Non-Hodgkin Lym... | Copanlisib Venetoclax | 18 Years - | Swiss Group for Clinical Cancer Research | |
| Agatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin Lymphoma | NCT00438880 | Adult Non-Hodgk... Extranodal Marg... Nodal Marginal ... Recurrent Adult... Recurrent Grade... Recurrent Grade... Recurrent Grade... Recurrent Mantl... Recurrent Margi... Recurrent Small... Splenic Margina... Waldenstrom Mac... | Agatolimod Sodi... Indium In-111 I... Laboratory Biom... Radionuclide Im... Rituximab Single Photon E... Yttrium Y-90 Ib... | 18 Years - | Mayo Clinic | |
| Study of Kappa Chimeric Antigen Receptor (CAR) T Lymphocytes Co-Expressing the Kappa and CD28 CARs for Relapsed/Refractory Kappa+ Non-Hodgkin Lymphoma and Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma. | NCT04223765 | Mantle Cell Lym... Follicular Lymp... Splenic Margina... Extranodal Marg... Nodal Marginal ... Indolent Non-ho... | CAR.k.28 Fludarabine Cyclophosphamid... Bendamustine | 18 Years - | UNC Lineberger Comprehensive Cancer Center | |
| Ibrutinib in Treating Relapsed or Refractory B-Cell Non-Hodgkin Lymphoma in Patients With HIV Infection | NCT02109224 | Adult B Acute L... Chronic Lymphoc... Cutaneous B-Cel... Extranodal Marg... HIV Infection Intraocular Lym... Multicentric An... Nodal Marginal ... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Adult... Recurrent Grade... Recurrent Grade... Recurrent Grade... Recurrent Mantl... Recurrent Margi... Recurrent Small... Refractory Chro... Refractory Hair... Refractory Plas... Small Intestina... Splenic Margina... Testicular Lymp... Waldenstrom Mac... | Ibrutinib Laboratory Biom... Pharmacological... | 18 Years - | National Cancer Institute (NCI) | |
| Integrated Molecular and Clinical Profiling to Improve Disease Characterization and Outcome Prediction in Nodal Marginal Zone Lymphoma | NCT05700149 | Nodal Marginal ... | 18 Years - | International Extranodal Lymphoma Study Group (IELSG) | ||
| Tumor Registry of Lymphatic Neoplasia | NCT00889798 | Non-Hodgkin's L... Chronic Lymphoc... Multiple Myelom... | 18 Years - | iOMEDICO AG | ||
| Agatolimod Sodium, Rituximab, and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Recurrent or Refractory Non-Hodgkin Lymphoma | NCT00438880 | Adult Non-Hodgk... Extranodal Marg... Nodal Marginal ... Recurrent Adult... Recurrent Grade... Recurrent Grade... Recurrent Grade... Recurrent Mantl... Recurrent Margi... Recurrent Small... Splenic Margina... Waldenstrom Mac... | Agatolimod Sodi... Indium In-111 I... Laboratory Biom... Radionuclide Im... Rituximab Single Photon E... Yttrium Y-90 Ib... | 18 Years - | Mayo Clinic |
Take Control of Your Skin and Body Changes Today.
Try out Spots for free, set up only takes 2 mins.
Join others from around the world:
